연구동향 분석

(The) immunomodulatory effects of thalidomide and corticosteroid combinatorial treatment on T cell subsets and the identification of the molecular mechanisms

김은지 2020년

논문상세정보
인용/피인용
' (The) immunomodulatory effects of thalidomide and corticosteroid combinatorial treatment on T cell subsets and the identification of the molecular mechanisms' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 4-1bb
  • OX40
  • ctla-4
  • dendritic cells
  • dexamethasone
  • gitr
  • immunomodulation
  • pd-1
  • t cells
  • t 세포
  • thalidomide
  • 면역조절
  • 수지상세포
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
187 0

0.0%

' (The) immunomodulatory effects of thalidomide and corticosteroid combinatorial treatment on T cell subsets and the identification of the molecular mechanisms' 의 참고문헌

  • Z. CD4+CD25+ regulatory T cells in tumor immunity
    34:244-9 [2016]
  • Xu W. Low-dose dexamethasone alleviates lipopolysaccharide-induced acute lung injury in rats and upregulates pulmonary glucocorticoid receptors
    13:772-80 [2008]
  • Use of glucocorticoids in the critical care setting : science and clinical evidence
  • Tumor necrosis factor receptor superfamily members and their ligands .
    6:407-13 [1994]
  • Treg and CTLA-4 : two intertwining pathways to immune tolerance
    45:49-57 [2013]
  • The suppression effects of thalidomide on human lung fibroblasts : cell proliferation , vascular endothelial growth factor release , and collagen production
    [2013]
  • The PD-1 pathway in tolerance and autoimmunity
    236:219-42 [2010]
  • The GITR-GITRL interaction : co-stimulation or contrasuppression of regulatory activity ?
    6:613-8 [2006]
  • Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2 , but not that activated by ceramide , lipopolysaccharides , or phorbol ester .
    168:2644-51 [2002]
  • Thalidomide and lenalidomide : Mechanism-based potential drug combinations
    [2008]
  • Thalidomide
    363:1802- 11 . [2004]
  • TNF/TNFR family members in costimulation of T cell responses
    23:23-68 [2005]
  • Suarez A. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity
    216:386-92 [2011]
  • Soroosh P. The significance of OX40 and OX40L to T-cell biology and immune disease
    229:173-91 [2009]
  • Role of Thalidomide on the Expression of OX40 , 4-1BB , and GITR in TCell Subsets
    48:1270-4 [2016]
  • Role of 4-1BB in immune responses
    10:481-9 [1998]
  • RiccardiC. Pharmacological modulation of GITRL/GITR system : therapeutic perspectives .
    165:2089-99 [2012]
  • RiccardiC. GITR/GITRL : more than an effector TCellCo-stimulatory system
    37:1165-9 [2007]
  • Regulatory T-cell functions are subverted andConverted owing to attenuated Foxp3 expression .
    445:766-70 [2007]
  • Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory TCells
    441:235-8 [2006]
  • Powrie F.Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function ofCD25 ( + )CD4 ( + ) regulatoryCells thatControl intestinal inflammation
    192:295-302 [2000]
  • Ono M. Regulatory T cells and immune tolerance
    133:775-87 [2008]
  • Offner H. Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis
    88:7-15 [2010]
  • OX40 ligand shuts down IL-10-producing regulatory T cells
    103:13138-43 [2006]
  • Novel roles of OX40 in the allograft response .
    13:26-30 [2008]
  • Negative Cardiovascular Consequences of Small Molecule Immunosuppressants
    102:269-76 [2017]
  • Molecular mechanisms of T cell co-stimulation and co-inhibition
    13:227-42 [2013]
  • Modulation of GITR for cancer immunotherapy .
    24:217-24 [2012]
  • Mehta A. TNF superfamily in inflammatory disease : translating basic insights
    33:144-52 [2012]
  • MartinezBanos D. Thalidomide and Dexamethasone Induction Therapy Until Best Response in Recently Diagnosed Patients with Multiple Myeloma : Results From a Pilot Study
    67:304-12 [2015]
  • M. Immune regulation and control of regulatory T cells by OX40 and 4-1BB
    19:253-62 [2008]
  • Longterm results of thalidomide and dexamethasone ( thal-dex ) as therapy of first relapse in multiple myeloma
    91:419-26 [2012]
  • Long-term side effects of glucocorticoids
    15:457-65 [2016]
  • Linn T. Anti-Inflammatory Thalidomide Improves Islet Grafts Survival and Functions in a Xenogenic Environment
    4 [2009]
  • Le Gros G. The role of CTLA-4 in the regulation of T cell immune responses
    77:1-10 [1999]
  • Involvement of cytokines in the modulation and progression of renal fibrosis induced by unilateral ureteral obstruction in C57BL/6 mice : effects of thalidomide and dexamethasone .
    30:35-46 [2016]
  • Immunologic self-tolerance maintained by CD25 ( + ) CD4 ( + ) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
    192:303-10 . [2000]
  • Immune modulatory effect of thalidomide on T cells
    47:787-90 [2015]
  • Immune modulation of some autoimmune diseases : the critical role of macrophages and neutrophils in the innate and adaptive immunity
    0.65 [2017]
  • Immune Modulation by Transplanted Calcium Phosphate Biomaterials and Human Mesenchymal Stromal Cells in Bone Regeneration
    0.877083333 [2019]
  • Glucocorticoid signaling : a nongenomic mechanism for T-cell immunosuppression
    13:158-63 [2007]
  • Glucocorticoid action and the development of selective glucocorticoid receptor ligands
    12:269-300 [2006]
  • Feige U. Dexamethasone enhances CTLA-4 expression during T cell activation
    55:1649-56 [1999]
  • Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells .
    70:353-6 [2009]
  • Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets
    152:628-37 [2017]
  • Eksioglu-Demiralp E. Thalidomide has both anti-inflammatory and regulatory effects in Behcet 's disease
    27:373-5 [2008]
  • Efficacy of thalidomide as immunossupressor in heterotopic heart transplantation .
    103:429-34 [2008]
  • Effects of immunosuppression induced by thalidomide and cyclosporine in heterotopic heart transplantation in rabbits
    39:1640-1 [2007]
  • Dexamethasone-induced immunosuppression : mechanisms and implications for immunotherapy .
    0.285416666666667 [2018]
  • Dexamethasone upregulates 11beta-hydroxysteroid dehydrogenase type 2 in BEAS-2B cells .
    167:1244-9 [2003]
  • Desai A. CTLA-4 and PD-1 Pathways : Similarities , Differences , and Implications of Their Inhibition
    39:98-106 [2016]
  • Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function
    200:2592-602 [2018]
  • Critical role of the programmed death-1 ( PD-1 ) pathway in regulation of experimental autoimmune encephalomyelitis
    198:71-8 [2003]
  • Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
    224:166-82 [2008]
  • Combination of bortezomib , thalidomide , and dexamethasone ( VTD ) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients
    100:159-64 [2014]
  • Chan C. Applications of immunohistochemistry in the evaluation of immunosuppressive agents
    19:251-4 [2000]
  • Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity
    17:1001-12 [2017]
  • Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naive T cells into cytokine-producing mature T cells
    7 : e31465 . [2012]
  • Attenuation of nephritis in lupus-prone mice by thalidomide .
    [2012]
  • Assessment of immunossupresion induced by thalidomide , cyclosporine and diclofenac on skin allograft survival in rabbits
    54:42-7 [2008]
  • Asadullah K. Mechanisms involved in the side effects of glucocorticoids
    96:23-43 [2002]
  • Arch RH . Tumor necrosis factor receptor ( TNFR ) -associated factor 5 is a critical intermediate of costimulatory signaling pathways triggered by glucocorticoid-induced TNFR in T cells
    281:8559-64 [2006]
  • 4-1BBdependent inhibition of immunosuppression by activated CD4+CD25+ T cells
    75:785-91 [2004]
  • 4-1BB and Ox40 are members of a tumor necrosis factor ( TNF ) -nerve growth factor receptor subfamily that bind TNF receptorassociated factors and activate nuclear factor kappa B. Molecular and Cellular Biology 1998
    18:558-65
  • 28. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 2009;9:271-85.